NSC |
Compound |
Enrichment |
Correlation |
NSC 59220 |
[[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt |
0.0181211508101519 |
0.36206172 |
NSC 610458 |
Camptothecin Derivative |
0.0181211508101519 |
0.67428242 |
NSC 627748 |
Null |
0.0181211508101519 |
0.20837997 |
NSC 638441 |
Null |
0.0181211508101519 |
0.44832376 |
NSC 653860 |
Null |
0.0181211508101519 |
0.64327301 |
NSC 659948 |
7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone |
0.0181211508101519 |
0.71955465 |
NSC 681639 |
Camptothecin Derivative |
0.0181211508101519 |
0.63030763 |
NSC 683661 |
Acetic acid, amino-, 9-[[(amino)carbonyl]oxy]-13-(2-amino- 1-oxoethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl- 3,20,22-trioxo-19-[(2-propenyl)amino]-2-azabicyclo [16.3.1]docosa-1(21),4,6,10,18-pentae |
0.0181211508101519 |
-0.027977279 |
NSC 685005 |
Null |
0.0181211508101519 |
-0.092910181 |
NSC 686550 |
Butanamide, N-(3-chloro-1,4-dioxo-2-naphthalenyl)- N-(1-oxobutyl)- |
0.0181211508101519 |
0.069897816 |